TOKYO -- Six leading investment banks guided the $62 billion takeover agreement between Takeda Pharmaceutical and Irish drugmaker Shire, handing a coup to Japanese and U.S. financial advisers.
Advising Takeda during its month-long courtship of Shire was Nomura Holdings, Japan's largest brokerage group. Nomura, which developed a long-term relationship with Takeda as its lead underwriter, fashioned a cash-and-stock proposal that eventually won over Shire's board.
